Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Thomas

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Journal of Biomedical Science|June 10, 2026
Selective molecular and network architecture features underlie brain cortical atrophy in dementia with Lewy bodiesAline Delva, Stephen Joza, Christina Tremblay, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2018
Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot StudyRíona Mc Ardle, Rosie Morris, Aodhán Hickey, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 14, 2026
Multicenter development and validation of a probability-based model to diagnose Lewy body disease using ¹²³I-meta-iodobenzylguanidineKenichi Nakajima, Junji Komatsu, Takeshi Matsumura, et al.
Bjpsych Open|October 25, 2024
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trialMonica Panca, Robert Howard, Elizabeth Cort, et al.
Nature Communications|September 24, 2022
DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-typesGemma Shireby, Emma L Dempster, Stefania Policicchio, et al.
International Journal of Geriatric Psychiatry|April 18, 2019
Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's diseaseEleanor King, John O'Brien, Paul Donaghy, et al.
International Journal of Geriatric Psychiatry|December 27, 2019
DETERMinants of quality of life, care and costs, and consequences of INequalities in people with Dementia and their carers (DETERMIND): A protocol paperNicolas Farina, Ben Hicks, Kate Baxter, et al.
Plos One|June 11, 2015
Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia StagesFrederic Blanc, Sean J Colloby, Nathalie Philippi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2025
Polygenic risk discriminates Lewy body dementia from Alzheimer's diseaseAnna McKeever, Peter Swann, Maura Malpetti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2024
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trialRobert Howard, Elizabeth Cort, Charlotte Rawlinson, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Journal of Biomedical Science|June 10, 2026
Selective molecular and network architecture features underlie brain cortical atrophy in dementia with Lewy bodiesAline Delva, Stephen Joza, Christina Tremblay, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2018
Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot StudyRíona Mc Ardle, Rosie Morris, Aodhán Hickey, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 14, 2026
Multicenter development and validation of a probability-based model to diagnose Lewy body disease using ¹²³I-meta-iodobenzylguanidineKenichi Nakajima, Junji Komatsu, Takeshi Matsumura, et al.
Bjpsych Open|October 25, 2024
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trialMonica Panca, Robert Howard, Elizabeth Cort, et al.
Nature Communications|September 24, 2022
DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-typesGemma Shireby, Emma L Dempster, Stefania Policicchio, et al.
International Journal of Geriatric Psychiatry|April 18, 2019
Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's diseaseEleanor King, John O'Brien, Paul Donaghy, et al.
International Journal of Geriatric Psychiatry|December 27, 2019
DETERMinants of quality of life, care and costs, and consequences of INequalities in people with Dementia and their carers (DETERMIND): A protocol paperNicolas Farina, Ben Hicks, Kate Baxter, et al.
Plos One|June 11, 2015
Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia StagesFrederic Blanc, Sean J Colloby, Nathalie Philippi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2025
Polygenic risk discriminates Lewy body dementia from Alzheimer's diseaseAnna McKeever, Peter Swann, Maura Malpetti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2024
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trialRobert Howard, Elizabeth Cort, Charlotte Rawlinson, et al.
Pageof 11